Sponsor Pipeline

Vivacta Biotechnology (Shanghai) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07614191 A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment… Moderate to Severe Refractory Autoimmune Diseases Recruiting
Get alerts when Vivacta Biotechnology (Shanghai) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free